CMS Implements Moratorium on Hospice and Home Care Provider Enrollment

In an effort to combat Medicare and Medicaid fraud, the Centers for Medicare and Medicaid Services (CMS) has implemented a six-month pause on the enrollment of new hospice and home care providers. Effective May 13, this decision classifies these sectors as high-risk for fraudulent activities, prompting enhanced scrutiny and regulatory measures.

During this suspension, CMS will utilize advanced data analytics and intensify investigations to swiftly address suspected fraudulent activities among hospice and home health providers. Despite similar state-level actions, this nationwide moratorium marks a rare initiative. According to Nicole Liebau from the Senior Medicare Patrol, the unprecedented nature of these suspensions parallels earlier actions against certain medical supply companies.

The focus on hospice and home health services arises from a surge in fraud allegations, highlighted by a report citing a disproportionate increase in hospice providers in Los Angeles County since 1983. The California attorney general's office has pursued numerous criminal prosecutions against hospice providers since 2021, emphasizing the critical need for rigorous risk management.

Industry response to the moratorium varies. The National Alliance for Care at Home acknowledges the importance of addressing fraud but cautions that the moratorium may inhibit access to care, particularly in rural areas. Conversely, organizations like LeadingAge support CMS's efforts, viewing the moratorium as a necessary step in safeguarding vulnerable populations.

The debate surrounding this CMS initiative underscores the ongoing challenge of balancing regulatory compliance with the provision of adequate healthcare services. Stakeholders continue to weigh in on the most effective strategies to ensure patient protection while fostering industry innovation.